We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+1.11%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.58B
AUM Growth
+$102M
Cap. Flow
+$70.6M
Cap. Flow %
2.74%
Top 10 Hldgs %
45.91%
Holding
71
New
22
Increased
18
Reduced
11
Closed
19

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$113M
2
HUM icon
Humana
HUM
+$98.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$93.7M
4
ELAN icon
Elanco Animal Health
ELAN
+$93.5M
5
ABT icon
Abbott
ABT
+$80.7M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$136M
2
HAE icon
Haemonetics
HAE
+$99.1M
3
AGN
Allergan plc
AGN
+$90.4M
4
DXCM icon
DexCom
DXCM
+$87M
5
MDT icon
Medtronic
MDT
+$81.3M

Sector Composition

Rank Sector Weight
1 Healthcare 91.39%
2 Technology 1.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMGI
51
DELISTED
Wright Medical Group Inc
WMGI
$2.98M 0.12%
100,000
-1,086,830
-92% -$33.1M
AXLA
52
DELISTED
Axcella Health Inc. Common Stock
AXLA
$1.59M 0.06%
+6,826
New +$2.16M
CVS icon
53
CALL
CVS Health
CVS
$133B
– –
-400,000
Closed -$21.6M
DTIL icon
54
Precision BioSciences
DTIL
$180M
– –
-5,000
Closed -$2.69M
DXCM icon
55
DexCom
DXCM
$31.5B
– –
-2,920,400
Closed -$87M
GNFT
56
DELISTED
Genfit
GNFT
– –
-325,000
Closed -$7.8M
ICLR icon
57
Icon
ICLR
$12.6B
– –
-408,730
Closed -$55.8M
IONS icon
58
PUT
Ionis Pharmaceuticals
IONS
$8.6B
– –
-125,000
Closed -$10.1M
IOVA icon
59
Iovance Biotherapeutics
IOVA
$1.82B
– –
-1,198,190
Closed -$11.4M
IRTC icon
60
iRhythm Holdings
IRTC
$3.85B
– –
-211,630
Closed -$15.9M
ISRG icon
61
Intuitive Surgical
ISRG
$127B
– –
-404,070
Closed -$76.9M
KPTI icon
62
Karyopharm Therapeutics
KPTI
$43.5M
– –
-19,742
Closed -$1.73M
PCRX icon
63
Pacira BioSciences
PCRX
$1.04B
– –
-706,379
Closed -$26.9M
SYK icon
64
PUT
Stryker
SYK
$125B
– –
-240,000
Closed -$47.4M
TMO icon
65
Thermo Fisher Scientific
TMO
$213B
– –
-157,520
Closed -$43.1M
ZBH icon
66
Zimmer Biomet
ZBH
$18.2B
– –
-1,095,086
Closed -$136M
CBAY
67
DELISTED
Cymabay Therapeutics
CBAY
– –
-224,640
Closed -$2.98M
AGN
68
DELISTED
Allergan plc
AGN
– –
-617,760
Closed -$90.4M
MDCO
69
CALL
DELISTED
Medicines Co
MDCO
– –
-1,000,000
Closed -$27.9M
MDCO
70
DELISTED
Medicines Co
MDCO
– –
-745,910
Closed -$20.8M
BHVN
71
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-152,040
Closed -$7.83M
1 2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q2 2019 Portfolio in Review

As of Q2 2019, HealthCor Management held 71 positions worth $2.58B, up 4.1% from $2.48B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

HealthCor Management's Q2 2019 filing shows 22 new, 18 increased, 11 reduced and 19 closed positions. Its largest new stake was Edwards Lifesciences: 1,866,690 shares worth $115M. The largest sale was Zimmer Biomet, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 87% a quarter earlier, followed by Technology.

  • HealthCor Management's largest Q2 2019 buy was Edwards Lifesciences: 1,866,690 shares worth $115M.
  • HealthCor Management added most to Humana in Q2 2019, an estimated $98.1M increase.
  • HealthCor Management's biggest Q2 2019 reduction was Haemonetics, cutting an estimated $99.1M.
  • HealthCor Management fully exited Zimmer Biomet in Q2 2019, selling an estimated $136M.
  • HealthCor Management's ten largest holdings make up 46% of its $2.58B portfolio in Q2 2019.
  • HealthCor Management opened 22 new positions and closed 19 in Q2 2019.
  • HealthCor Management's portfolio value rose 4.1% quarter-over-quarter to $2.58B.

Based on HealthCor Management's 13F filing for Q2 2019, filed 14 Aug 2019.